Peripheral Neuropathy Trial, Recruiting NCT04587648 Sponsor: National Taiwan University Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT04587648
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 60 years of age or older, or people who are 50 years of age or older and have been diagnosed with carpal tunnel syndrome or spinal stenosis
  • People who have been diagnosed with a specific type of heart failure called HFpEF (heart failure with preserved ejection fraction), either previously or recently, with heart failure symptoms ranging from mild to severe
  • People where more than half of those enrolled have a thickened heart wall measurement of 12mm or more at the time of diagnosis (confirm with trial site)
  • People who are able and willing to provide written consent to take part

Who may not be able to join:

  • People who are not willing to take part in the trial
  • People who have unstable coronary artery disease (an ongoing problem with blood supply to the heart) or who are planning to have a procedure to treat blocked heart arteries within the coming months
  • People who have a history of a different type of heart failure, known as HFrEF, where the heart's pumping function was measured at less than 40%

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2019
Est. completion
31 December 2022

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Prevalence of ATTRwt among patients with HFpEF in Taiwan

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov